why choose us

First received: December 20, 2022

Clinical Trial: A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Recurrent High Grade Glioma

Study Type: INTERVENTIONAL


Official Title: A Phase I Study of Metronomic Temozolomide With Abexinostat (PCI-24781) for Patients With Recurrent High Grade Glioma

Brief Summary: The goal of this clinical trial is to learn about treatment for a type of brain cancer called glioma.This clinical trial is for people with glioma who have been cancer-free for a period of time but their cancer has come back.The primary goals of this clinical trial are the following:To determine the recommended dose of PCI-24781/Abexinostat with metronomic temozolomideTo evaluate side effects associated with using PCI-24781/Abexinostat with metronomic temozolomide

Read more